Literature DB >> 24333319

Clinical use and the Italian demand for antithrombin.

Giancarlo M Liumbruno1, Massimo Franchini2, Monica Lanzoni3, Fabio Candura4, Stefania Vaglio5, Samantha Profili4, Liviana Catalano4, Giuseppina Facco6, Simonetta Pupella4, Gabriele Calizzani4, Giuliano Grazzini4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24333319      PMCID： PMC3853981          DOI： 10.2450/2013.014s

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  34 in total

1.  Investigation and management of heritable thrombophilia.

Authors: 
Journal:  Br J Haematol       Date:  2001-09       Impact factor: 6.998

2.  Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates.

Authors:  Giancarlo Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

Review 3.  2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines.

Authors:  Victor A Ferraris; Jeremiah R Brown; George J Despotis; John W Hammon; T Brett Reece; Sibu P Saha; Howard K Song; Ellen R Clough; Linda J Shore-Lesserson; Lawrence T Goodnough; C David Mazer; Aryeh Shander; Mark Stafford-Smith; Jonathan Waters; Robert A Baker; Timothy A Dickinson; Daniel J FitzGerald; Donald S Likosky; Kenneth G Shann
Journal:  Ann Thorac Surg       Date:  2011-03       Impact factor: 4.330

Review 4.  Thrombophilia in pregnancy: a systematic review.

Authors:  L Robertson; O Wu; P Langhorne; S Twaddle; P Clark; G D O Lowe; I D Walker; M Greaves; I Brenkel; L Regan; I A Greer
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

5.  Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines.

Authors:  H Wada; J Thachil; M Di Nisio; P Mathew; S Kurosawa; S Gando; H K Kim; J D Nielsen; C-E Dempfle; M Levi; C-H Toh
Journal:  J Thromb Haemost       Date:  2013-02-04       Impact factor: 5.824

Review 6.  Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.

Authors:  George M Rodgers
Journal:  Thromb Haemost       Date:  2009-05       Impact factor: 5.249

Review 7.  Selective inhibition of coagulation factors: advances in antithrombotic therapy.

Authors:  Kenneth A Bauer
Journal:  Semin Thromb Hemost       Date:  2002-06       Impact factor: 4.180

Review 8.  Treating heparin resistance with antithrombin or fresh frozen plasma.

Authors:  Bruce D Spiess
Journal:  Ann Thorac Surg       Date:  2008-06       Impact factor: 4.330

Review 9.  Antithrombin III for critically ill patients.

Authors:  Arash Afshari; Jørn Wetterslev; Jesper Brok; Ann Merete Møller
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

Review 10.  Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum.

Authors:  Arturo J Martí-Carvajal; Gabriella Comunián-Carrasco; Guiomar E Peña-Martí
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16
View more
  5 in total

Review 1.  Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.

Authors:  Toshiaki Iba; Jecko Thachil
Journal:  Int J Hematol       Date:  2015-11-20       Impact factor: 2.490

Review 2.  Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.

Authors:  Gabriele Calizzani; Samantha Profili; Fabio Candura; Monica Lanzoni; Stefania Vaglio; Livia Cannata; Liviana Catalano; Rosa Chianese; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

3.  Plasma-derived medicinal products: demand and clinical use.

Authors:  Giuliano Grazzini; Pier Mannuccio Mannucci; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

4.  Controversies regarding the use of antithrombin for sepsis-associated disseminated intravascular coagulation: an update of the evidence.

Authors:  Toshiaki Iba
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

5.  Impact of Antithrombin Supplementation and Concomitant Anticoagulation Therapy in Pediatric Patients With Disseminated Intravascular Coagulation.

Authors:  Hiroyuki Nagafuchi; Yutaka Eguchi; Toshiaki Ikeda
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.